Latest News and Press Releases

BitFuFu announces its unaudited financial results for the quarter ended March 31, 2025.

CALGARY, Alberta, May 29, 2025 (GLOBE NEWSWIRE) -- Reconnaissance Energy Africa Ltd. (the “Company” or “ReconAfrica”) (TSXV: RECO) (OTCQX: RECAF) (Frankfurt: 0XD) (NSX: REC) announces the filing of...

BitFuFu will release its unaudited financial results for the quarter ended March 31, 2025, before the U.S. market open on June 5, 2025.

Consolidated revenue for Q1 2025 improved 7.5% year-over-year, to $121 million.Logistics revenue increased 17.6% year-over-year, driven by 9% volume growth, highlighting continued customer wins and...

Magnite Reports First Quarter 2025 Results

NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Unlimited, an asset management firm and ETF sponsor that uses proprietary technology to provide low-cost, alternative strategies to a variety of investors,...

Telix Pharmaceuticals reported strong Q1 2025 revenue of $186 million, up 62% year-on-year, driven by Illuccix® sales and RLS Radiopharmacies acquisition.

La FDA approuve EGRIFTA WRMC (la formulation F8 de la tésamoréline) pour traiter l’excès de graisse viscérale abdominale chez les adultes vivant avec le VIH atteints de lipodystrophieLes revenus...

FDA Approves EGRIFTA WR™ (Tesamorelin F8) to Treat Excess Visceral Abdominal Fat in Adults with HIV and LipodystrophyTotal Revenue $19 million, representing +17% growth year over yearFDA Approves...

MONTRÉAL, 03 avr. 2025 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique au stade commercial,...